Sawgrass Asset Management LLC Halozyme Therapeutics, Inc. Transaction History

Sawgrass Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$39.51 - $51.45 $338,995 - $441,441	-8,580 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$25.81 - $43.62 $142,342 - $240,564	-5,515 Reduced 39.13%	8,580 $366,000
Q3 2020 Nov 02, 2020	BUY	$25.74 - $29.63 $54,311 - $62,519	2,110 Added 17.61%	14,095 $370,000
Q2 2020 Jul 27, 2020	BUY	$16.25 - $26.81 $194,756 - $321,317	11,985 New	11,985 $321,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sawgrass Asset Management LLC with notifications on news.